More than two-dozen cancer investigators from Winship Cancer Institute of Emory University will present their research at the American Association for Cancer Research (AACR) Annual Meeting in Philadelphia, April 18-22.
The conference will attract more than 18,500 scientists, clinicians, advocates and others in the field of cancer science. More than 5,800 annual meeting abstracts will be released during the session including studies by Winship researchers related to treatment of patients with melanoma, myeloma, renal cell cancer and non-small cell lung cancer (NSCLC).
Winship researcher Xingming Deng, PhD, looks at a novel strategy for improving lung cancer outcomes in patients by using a small molecule antagonist to the Bcl2.
Daniel J. Brat, MD, PhD, will present a paper on diffuse gliomas. Winship's Executive Director Walter J. Curran, Jr., MD, says the work "may transform our approach to patients with low grade gliomas."
Emory researcher Alice O. Kamphorst, PhD, will present a study evaluating biomarkers for targeted therapies in NSCLC patients. Another study by Maggie L. Diller, MD, will discuss her research into combining specific therapies in patients with advanced melanoma.
Visit the AACR Annual Meeting website for a complete list of abstracts.